Home › Funds › SPHERA FUNDS MANAGEMENT LTD. › ELDN

SPHERA FUNDS MANAGEMENT LTD. position in ELDN

ELEDON PHARMACEUTICALS INC · Health Care

SPHERA FUNDS MANAGEMENT LTD. reported holding 1,191,187 shares of ELDN (ELEDON PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$4.7M, representing 0.66% of its reported portfolio and ranking #50 among its reported holdings. SPHERA FUNDS MANAGEMENT LTD. has disclosed ELDN holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)1.19M sh
Reported value held$4.69M
Portfolio Weight0.66%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How SPHERA FUNDS MANAGEMENT LTD.'s ELDN position evolved

SPHERA FUNDS MANAGEMENT LTD. first disclosed a stake in ELDN in Q2 2024 at 1,297,021 shares (US$3.4M). The position peaked in Q4 2024 at 2,551,619 shares, worth US$10.5M. Across 9 filings, SPHERA FUNDS MANAGEMENT LTD. increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,191,187 shares valued at US$4.7M — a reduction of -580,944 shares quarter over quarter.. Notable position changes include a 99% trim in Q2 2025 (shares fell 4% over the following quarter), a 541% increase in Q3 2025 (shares fell 42% over the following quarter), a 966% increase in Q4 2025 (shares rose 104% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 1.30M $3.42M New
Q3 2024 1.30M $3.23M Hold
Q4 2024 2.55M $10.51M Add
Q1 2025 2.31M $7.82M Reduce
Q2 2025 31.20K $84.55K Reduce
Q3 2025 200.00K $518.00K Add
Q4 2025 2.13M $3.22M Add
Q1 2026 1.77M $5.46M Reduce
Q2 2026 1.19M $4.69M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELDN and 13F data

ELDN (ELEDON PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in ELDN — the largest reported positions include BVF INC/IL (US$24.8M), Defilade Capital Management, L.P. (US$13.9M), Catalio Capital Management, LP (US$6.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELDN

All ELDN fund holders →

FAQ

How long has SPHERA FUNDS MANAGEMENT LTD. held ELDN?

SPHERA FUNDS MANAGEMENT LTD. has disclosed ELDN holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is SPHERA FUNDS MANAGEMENT LTD.'s current position in ELDN?

As of Q2 2026, SPHERA FUNDS MANAGEMENT LTD. holds 1.19M shares of ELDN (ELEDON PHARMACEUTICALS INC), valued at $4.69M, representing 0.66% of its reported portfolio and ranking #50.

Has SPHERA FUNDS MANAGEMENT LTD. been buying or selling ELDN?

In the latest 13F filing (Q2 2026), SPHERA FUNDS MANAGEMENT LTD. reduced its position in ELDN. The position peaked in Q4 2024 at 2.55M shares.

Which other funds hold ELDN?

Other major institutional holders of ELDN include BVF INC/IL, Defilade Capital Management, L.P., Catalio Capital Management, LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.